These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 3468207

  • 1. Modulation in vitro and in vivo of ACNU resistance in a subline of C6 glioma with reserpine.
    Yoshida T, Shimizu K, Ushio Y, Mogami H, Sakamoto Y.
    J Neurosurg; 1987 Feb; 66(2):251-5. PubMed ID: 3468207
    [Abstract] [Full Text] [Related]

  • 2. [Overcoming of ACNU resistance in a subline of rat glioma in vitro and in vivo by reserpine].
    Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Mogami H, Sakamoto Y.
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2141-6. PubMed ID: 3459396
    [Abstract] [Full Text] [Related]

  • 3. [Enhanced effect of reserpine on growth-inhibitory action of ACNU on ACNU resistance C6 glioma].
    Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Mogami H, Sakamoto Y.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):464-6. PubMed ID: 6584086
    [Abstract] [Full Text] [Related]

  • 4. [Possibility of overcoming of ACNU resistance in an ACNU-resistant subline of C6 rat glioma].
    Yoshida T, Shimizu K, Ushio Y, Mogami H, Sakamoto Y.
    No To Shinkei; 1986 Nov; 38(11):1065-70. PubMed ID: 3468959
    [Abstract] [Full Text] [Related]

  • 5. Enhanced effect of reserpine upon growth-inhibitory action of ACNU on ACNU-resistant C6 glioma.
    Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Mogami H, Sakamoto Y.
    Br J Cancer; 1986 Jun; 53(6):773-7. PubMed ID: 3459511
    [Abstract] [Full Text] [Related]

  • 6. [Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor].
    Yoshida T, Shimizu K, Hayakawa T, Mogami H, Sakamoto Y, Egawa T.
    No Shinkei Geka; 1987 Mar; 15(3):261-7. PubMed ID: 3474542
    [Abstract] [Full Text] [Related]

  • 7. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
    Yoshida T, Ushio Y, Hayakawa T, Yamada K, Kato A, Mogami H, Nakata Y.
    No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
    [Abstract] [Full Text] [Related]

  • 8. The mechanism and overcoming of resistance in ACNU-resistant sublines of C6 and 9L rat glioma.
    Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Mogami H, Sakamoto Y.
    J Neurooncol; 1987 Aug; 5(3):195-203. PubMed ID: 3479534
    [Abstract] [Full Text] [Related]

  • 9. [Studies on the mechanism of ACNU resistance in sublines of rat C6 glioma and 9L gliosarcoma in vitro].
    Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Kato A, Mogami H, Sakamoto Y.
    No Shinkei Geka; 1986 Oct; 14(11):1299-304. PubMed ID: 3468375
    [Abstract] [Full Text] [Related]

  • 10. [Possibility of overcoming ACNU resistance in ACNU-resistant sublines of rat brain tumors in vitro by a calmodulin inhibitor].
    Yoshida T, Shimizu K, Mogami H, Sakamoto Y, Egawa T.
    No Shinkei Geka; 1987 Feb; 15(2):143-9. PubMed ID: 3470626
    [Abstract] [Full Text] [Related]

  • 11. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
    Yoshida T, Shimizu K, Mogami H, Egawa T, Sakamoto Y.
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
    [Abstract] [Full Text] [Related]

  • 12. Isolation and preliminary characterization of ACNU-resistant sublines of rat brain tumors in vivo.
    Yoshida TK, Shimizu K, Koulousakis A, Sturm V, Beuls E.
    J Neurosurg; 1992 Sep; 77(3):451-6. PubMed ID: 1506893
    [Abstract] [Full Text] [Related]

  • 13. Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration.
    Mineura K, Watanabe K, Izumi I, Kowada M.
    J Neurooncol; 1992 Nov; 14(3):201-5. PubMed ID: 1460484
    [Abstract] [Full Text] [Related]

  • 14. ACNU-resistant mutants of 9L rat glioma cell line. Isolation and preliminary characterization of these subclones.
    Kokunai T, Tamaki N, Matsumoto S.
    J Neurosurg; 1985 Oct; 63(4):583-8. PubMed ID: 3861792
    [Abstract] [Full Text] [Related]

  • 15. [Enhancing effect of reserpine upon the cytotoxicity of ACNU on ACNU-resistant glioma cells].
    Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Mogami H, Sakamoto Y.
    Neurol Med Chir (Tokyo); 1986 Dec; 26(12):925-30. PubMed ID: 2438568
    [No Abstract] [Full Text] [Related]

  • 16. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
    Yoshida TK, Shimizu K, Koulousakis A, Sturm V.
    J Neurosurg; 1992 Nov; 77(5):778-82. PubMed ID: 1403122
    [Abstract] [Full Text] [Related]

  • 17. Intrathecal chemotherapy with ACNU for meningeal gliomatosis.
    Yoshida TK, Beuls E, Shimizu K, Koulousakis A, Sturm V.
    Br J Cancer; 1992 Dec; 66(6):999-1004. PubMed ID: 1457369
    [Abstract] [Full Text] [Related]

  • 18. Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells.
    Nakagawa T, Kubota T, Ido K, Sakuma T, Matsuda K.
    J Neurooncol; 2006 Sep; 79(3):271-9. PubMed ID: 16645721
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) of glioma cells in vivo and in vitro.
    Yoshida J, Shibuya N, Kobayashi T, Kageyama N.
    Cancer; 1982 Aug 01; 50(3):410-8. PubMed ID: 6953989
    [Abstract] [Full Text] [Related]

  • 20. Potential of O6-methylguanine or O6-benzylguanine in the enhancement of chloroethylnitrosourea cytotoxicity on brain tumours.
    Mineura K, Izumi I, Watanabe K, Kowada M, Kohda K, Ikenaga M.
    Acta Neurochir (Wien); 1994 Aug 01; 128(1-4):13-20. PubMed ID: 7847129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.